F2 and COVID-19: Besides, the activity of prothrombin was also elevated in COVID-19 patients with an increased amount of prothrombin fragment 1.2 in serum, which can be used as a marker identifying thrombotic manifestations in hospitalized patients with COVID-19 [44].